WuXi’s STA Biotech CMC Outsourcing Boston Symposium Recap

WuXi’s STA Pharmaceutical recently hosted a knowledge sharing and networking symposium, “Biotech CMC Outsourcing Strategies – Boston.” More than 100 industry CMC professionals and collaborators participated in this event, which focused...

WuXi’s STA Leaders Provide Industry Trends and Insights During CPhI Worldwide 2016

More than 36,000 pharma professionals from over 150 countries attended the CPhI Worldwide 2016 convention in Barcelona Spain earlier this month to stay updated on the latest industry trends, meet with global...

WuXi AppTec Unveils Manufacturing Center for Cutting Edge Cell and Gene Therapies

We are thrilled to announce the grand opening of our Center for Clinical and Commercial Manufacturing of Advanced Therapies in the Philadelphia Navy Yard. The 150,000 square foot biomanufacturing facility is designed...

WuXi Biologics Completes Construction of Asia’s Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreactors

We are pleased to announce the opening of our new commercial-scale cGMP biologics perfusion manufacturing facility in the city of Wuxi, China. The $150 million commercial biologics manufacturing facility accommodates two 1000L...
WuXi Receives Merck Awards for Achieving Team Milestones

WuXi’s Partnership with Eli Lilly to Bring Novel Cardiovascular Medicines to China Named...

We are honored to be named a finalist in the 2016 Scrip Awards for Best Partnership Alliance for our collaboration with Eli Lilly to develop, manufacture, and commercialize a small-molecule drug...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS